What progress is being made in senolytics, gene editing, immunotherapy, mitochondrial restoration, indication expansion, neutraceuticals, peptides, stem cells … ?
Pipeline
What companies are moving through the drug development pipeline towards in-human studies and ultimately the approval to market true rejuvenation therapies?
Expectation-setting
With the toning-down of the ‘1000 year lifespan’ rhetoric, there is growing confidence in the sciences of healthspan and lifespan: what should we expect within our lifetimes?
